ArticleBMC infectious diseases2024

Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments.

Laura-Amanda Vallejo Aparicio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.